The interplay of rheumatoid arthritis and osteoporosis: exploring the pathogenesis and pharmacological approaches

Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis

Kenneth G. Saag, Jeffrey Petersen, Maria Luisa Brandi et al. · New England Journal of Medicine · 2017 · 1.5K citations · Full text

Medicine, Orthopedic Surgery, Bone Augmentation +16

Dickkopf-1 is a master regulator of joint remodeling

Danielle Diarra, Marina Stolina, Karin Polzer et al. · Nature Medicine · 2007 · 1.3K citations

Medicine, Molecular Genetics, Orthopedic Surgery +4

Romosozumab in Postmenopausal Women with Low Bone Mineral Density

Michael R. McClung, Andreas Grauer, Steven Boonen et al. · New England Journal of Medicine · 2014 · 1.2K citations

Medicine, Endocrinology, Bone Metabolism +12

Involvement of receptor activator of nuclear factor κB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis

Hiroshi Takayanagi, Hideharu Iizuka, Takuo Juji et al. · Arthritis & Rheumatism · 2000 · 604 citations · Full text

Medicine, Immunology, Bone Metabolism +16

Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve‐month, multicenter, randomized, double‐blind, placebo‐controlled, phase II clinical trial

Stanley Cohen, Robin K. Dore, Nancy E. Lane et al. · Arthritis & Rheumatism · 2008 · 570 citations

Medicine, Pharmacology, Pharmacotherapy +17